Back to results
RecruitingPhase 1

Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease

NCT05901818

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Xuanwu Hospital Capital Medical University

Beijing, Beijing Municipality, China

Contact

Zhiguo Chen, Ph.D.

+86-10-83198889chenzhiguo@gmail.com
View on ClinicalTrials.gov
Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease — TrialFind